Sensitive analytical method for Topiramate in human serum by HPLC with pre-column fluorescent derivatization and its application in human pharmacokinetic studies.

[1]  J. Poulsen,et al.  Liquid Chromatography Tandem Mass Spectrometry Assay for Topiramate Analysis in Plasma and Cerebrospinal Fluid: Validation and Comparison With Fluorescence-Polarization Immunoassay , 2002, Therapeutic drug monitoring.

[2]  H. Duong,et al.  A HPLC assay for coating integrity of topiramate sprinkle formulation. , 2002, Journal of pharmaceutical and biomedical analysis.

[3]  P. Carvey,et al.  Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma. , 2001, Rapid communications in mass spectrometry : RCM.

[4]  P. Patsalos,et al.  Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay. , 2000, Therapeutic drug monitoring.

[5]  T. Glauser,et al.  An improved gas chromatography assay for topiramate monitoring in pediatric patients. , 2000, Therapeutic drug monitoring.

[6]  E. Perucca,et al.  Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants? , 2000, Clinical pharmacokinetics.

[7]  P. Carvey,et al.  Rapid approach to the quantitative determination of topiramate (2, 3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.

[8]  R. Stubbs,et al.  A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood. , 1999, Journal of pharmaceutical and biomedical analysis.

[9]  R. Shank,et al.  In vivo microdialysis and liquid chromatography/thermospray mass spectrometry of the novel anticonvulsant 2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate (topiramate) in rat brain fluid. , 1998, Journal of mass spectrometry : JMS.

[10]  R. Davis,et al.  Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. , 1997, Drugs.

[11]  W. Rosenfeld.  Topiramate: a review of preclinical, pharmacokinetic, and clinical data. , 1997, Clinical therapeutics.